SEC Form 4 · accession 0001209191-15-034341
IRONWOOD PHARMACEUTICALS INC · IRWD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George H Conrades
Director
Period of report
Feb 17, 2015
Accepted (ET)
Apr 15, 2015 · 4:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001446847
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class B Common StockF2 | Feb 17, 2015 | J | 254,152 | — | D | 0 | I | By Conrades Family, LLC |
| Class A Common Stock | holding | — | — | — | 45,665 | D | ||
| Class B Common Stock | holding | — | — | — | 90,000 | D | ||
| Class B Common StockF3 | holding | — | — | — | 483,755 | I | By Longfellow Venture Partners I, LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reported securities are held by Conrades Family, LLC (the "LLC") of which the reporting person had been a manager and member. On February 17, 2015, the reporting person and his spouse transferred their voting interests in the LLC. The reporting person is no longer a manager of the LLC and is not deemed to have a pecuniary interest in the issuer's securities held by the LLC.
- F2$15.41 was the closing market price per share of the issuer's Class A Common Stock on the date of the transfer, as reported by NASDAQ.
- F3The reporting person is the sole manager of Longfellow Venture Partners I, LLC, the beneficial owner of the securities. The reporting person disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein.